SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Ingredients: Top Headlines

News in brief

SK Capital will pay $110m for Perrigo's drug ingredients business

14-Aug-2017 - SK Capital has said it will buy Perrigo Company Plc’s drug ingredients business for $110m (€85m) in cash.

Avara agrees to buy ex-Hospira plant in Italy from Pfizer

10-Aug-2017 - Avara Pharmaceutical Services has agreed to buy Pfizer Inc. sterile drug manufacturing facility in Liscate, Italy.

update

Teva confirms API plant will be among 15 sites shut in cost cutting plan

07-Aug-2017 - Teva Pharmaceutical Industries Ltd has confirmed its API plant in Netanya, Israel will close as part of the cost reduction programme announced last week.

Cambrex sees Q2 revs and earnings rise, confirms interest in takeovers

07-Aug-2017 - Cambrex Corporation says higher demand for APIs for controlled substances and branded drugs drove Q2 growth and confirms it is on the lookout for acquisitions. 

News in brief

Pfizer's API business revenue falls 13% on lower international sales

03-Aug-2017 - Revenue generated by Pfizer’s API and contracting business fell in the second quarter.

Scinopharm hired to make API for skin infection antibiotic Baxdela

03-Aug-2017 - Melinta Therapeutics has hired ScinoPharm to make the active pharmaceutical ingredient (API) for Baxdela, an antibiotic for skin infections that was recently approved by the US FDA.

Fosun and KKR extend deadline for $1.2bn Gland Pharma deal

01-Aug-2017 - Shanghai Fosun Pharma and KKR have agreed to extended the termination date for the former's proposed $1.2bn takeover of Gland Pharma.

Ingredients: Featured news

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...